Bristol Myers Squibb (BMY)

SG&A Expenses

$1.83B

Quarterly · Period ending: · USD

BMY logo

BMY SG&A Expenses

Latest reported$1.83B
BMY Quarterly SG&A Expenses ($0.00 → $1.83B)
High-resolution chart · PNG

BMY sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
1,826,000,000
1,617,000,000
2,181,000,000
1,789,000,000
1,713,000,000
1,584,000,000
2,136,000,000
1,983,000,000
1,928,000,000
2,367,000,000
2,073,000,000
2,003,000,000
1,934,000,000
1,762,000,000
2,266,000,000
1,930,000,000
1,787,000,000
1,831,000,000
2,354,000,000
1,788,000,000
1,882,000,000
1,666,000,000
2,721,000,000
1,706,000,000
1,628,000,000
1,606,000,000
1,734,000,000
1,055,000,000
1,076,000,000
1,006,000,000
1,336,000,000
1,104,000,000
1,131,000,000
980,000,000
1,370,000,000
1,163,000,000
1,187,000,000
1,085,000,000
1,486,000,000
1,163,000,000
1,263,000,000
1,090,000,000
1,550,000,000
1,224,000,000
1,171,000,000
1,056,000,000
2,104,000,000
1,228,000,000
1,183,000,000
1,184,000,000
1,349,000,000
1,211,000,000
1,361,000,000
1,183,000,000
1,513,000,000
1,241,000,000
1,228,000,000
1,196,000,000
1,501,000,000
1,224,000,000
1,293,000,000
1,142,000,000
1,268,000,000
1,123,000,000
1,157,000,000
1,112,000,000
739,000,000
1,209,000,000
1,248,000,000
1,253,000,000
1,767,000,000
1,570,000,000
1,585,000,000
1,453,000,000
1,751,000,000
1,443,000,000
1,457,000,000
1,401,000,000
1,729,000,000
1,475,000,000
1,533,000,000
1,533,000,000
1,813,000,000
1,635,000,000
1,633,000,000
1,501,000,000
1,785,000,000
1,524,000,000
1,547,000,000
1,542,000,000
1,711,000,000
1,483,000,000
1,501,000,000
1,415,000,000
1,492,000,000
1,273,000,000
1,282,000,000
1,171,000,000
1,441,000,000
1,186,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.